Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Pfizer Global Research and Development
Femme et Homme Max 99 ans
Pfizer Global Research and Development
MAJ Il y a 4 ans
Linezolid vs. Vancomycin/Oxacillin/Dicloxacillin in the Treatment of Catheter-Related Gram Positive Bloodstream Infections
The primary objective of this study is to compare the microbiological efficacy of linezolid to vancomycin/oxacillin/dicloxacillin in the empiric treatment of patients with gram-positive catheter-relat...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Limited. Pfizer Global Research and Development
MAJ Il y a 4 ans
Full title of the trial: A 9 Week, Randomized, Double-Blind, placebo-controlled, Multicenter, Study of Pregabalin (BID) in subjects with posttraumatic peripheral neuropathic pain
To evaluate the efficacy of pregabalin compared to placebo in the treatment of post traumatic peripheral neuropathic pain.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Global Research and Development (USA)
MAJ Il y a 4 ans
An Evaluation of the Effects of Roflumilast on Cardiac Repolarization, Pharmacokinetics, Safety, and Tolerability in Healthy Volunteers
Not provided at time of registration
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Pfizer Global Research and Development
MAJ Il y a 4 ans
A Phase 1/2, Randomized, Masked, Single and Multiple-Dose, Sequential Dose-Escalation Study of the Safety and Efficacy of AG-013958 in Subjects with Subfoveal Choroidal Neovascularization Associated with Age-related Macular Degeneration
To determine the ocular and systemic safety of AG-013958 Suspension for Injection for 13 weeks following administration of a single ST injection and for 104 weeks following multiple administrations by...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Homme Max 99 ans
Pfizer Global Research and Development
MAJ Il y a 4 ans
An open label, two period crossover study to explore the safety, pharmacokinetics and pharmacodynamics of PHA-794428 after single subcutaneous injections in adult male patients with growth hormone deficiency
To explore the pharmacokinetics and pharmacodynamics of PHA-794428 after single subcutaneous injections in AGHD patients in order to support the development of a PK/PD model in this patient population...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations